These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26418829)

  • 1. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
    Cheng W; Tang C; Yin C
    J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages.
    Zhang J; Tang C; Yin C
    Biomaterials; 2013 May; 34(14):3667-77. PubMed ID: 23419643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
    He C; Yin L; Tang C; Yin C
    Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
    He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
    Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles.
    Chu S; Tang C; Yin C
    Biomaterials; 2015 Jun; 52():229-39. PubMed ID: 25818429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
    Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
    He C; Yin L; Song Y; Tang C; Yin C
    Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
    Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
    J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.
    Attarwala H; Clausen V; Chaturvedi P; Amiji MM
    Mol Pharm; 2017 Sep; 14(9):3036-3044. PubMed ID: 28737923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
    Huang Y; Guo J; Gui S
    Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
    Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
    Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of binding affinity for siRNA on the in vivo antitumor efficacy of polyplexes.
    Han L; Tang C; Yin C
    Biomaterials; 2013 Jul; 34(21):5317-27. PubMed ID: 23591392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
    Han L; Tang C; Yin C
    Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
    Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
    Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of inflammation in a chronic periodontitis model in rats by TNF-α gene silencing with a topically applied siRNA-loaded calcium phosphate paste.
    Tenkumo T; Rojas-Sánchez L; Vanegas Sáenz JR; Ogawa T; Miyashita M; Yoda N; Prymak O; Sokolova V; Sasaki K; Epple M
    Acta Biomater; 2020 Mar; 105():263-279. PubMed ID: 31982590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.
    He C; Yin L; Tang C; Yin C
    Pharm Res; 2013 Oct; 30(10):2596-606. PubMed ID: 23715740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system.
    McCarthy J; O'Neill MJ; Bourre L; Walsh D; Quinlan A; Hurley G; Ogier J; Shanahan F; Melgar S; Darcy R; O'Driscoll CM
    J Control Release; 2013 May; 168(1):28-34. PubMed ID: 23500058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
    Wilson DS; Dalmasso G; Wang L; Sitaraman SV; Merlin D; Murthy N
    Nat Mater; 2010 Nov; 9(11):923-8. PubMed ID: 20935658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Ginger-Derived Extracellular Vesicles-Coated ZIF-8 Containing TNF-α siRNA for Ulcerative Colitis Therapy by Modulating Gut Microbiota.
    Cui C; Du M; Zhao Y; Tang J; Liu M; Min G; Chen R; Zhang Q; Sun Z; Weng H
    ACS Appl Mater Interfaces; 2024 Oct; 16(40):53460-53473. PubMed ID: 39303016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.